FMC Corp. closed $6.03 below its 52-week high ($68.72), which the company achieved on May 13th.

B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.

The initiative aims to enhance production efficiency and reduce the risk of human error-induced inconsistencies.

Germany's Fresenius said it was checking options to speed up the start of new production lines of medical equipment at a ...

Two major hurricanes have had medtech companies, including Baxter, B. Braun and Fresenius, scrambling to prevent a U.S. IV ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Cellular Origins and Fresenius Kabi have partnered to integrate Fresenius Kabi's cell therapy processing tech with Cellular ...